Sun Pharmaceutical Industries Ltd and its subsidiaries or associate companies announced its plans to acquire a branded oncology product, Odomzo...
Novartis announced the FDA has approved Odomzo (sonidegib, formerly LDE225) 200 mg capsules for the treatment of adult patients with...
On 25 June 2015, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting...
The European Commission has approved Odomzo (sonidegib, formerly LDE225) 200 mg capsules, from Novartis, for the treatment of adult patients...
The Hedgehog (Hh) pathway is critical for cell differentiation, tissue polarity, and stem cell maintenance during embryonic development, but is silent in adult tissues under normal conditions.